• Redefining Energy Mapping: ATP Assays in Inflammatory Diseas

  2026-04-30

  This thought-leadership article explores how advanced luminescent ATP detection technologies, exemplified by APExBIO’s Luminescent ATP Detection Assay Kit, are revolutionizing translational research in complex inflammatory disease models such as ulcerative colitis. By integrating mechanistic insight into the NOX2/ROS/mitochondria/NLRP3 axis with strategic laboratory guidance, this piece provides a roadmap for leveraging precision ATP quantification in the pursuit of novel therapies. Expanding on recent mechanistic studies and bridging cellular bioenergetics with real-world assay design, we delineate both the competitive landscape and future outlook for ATP-centric workflows.

• Palonosetron Hydrochloride in Preventing CINV: Mechanistic a

  2026-04-30

  This article examines the pharmacological innovation and clinical relevance of palonosetron hydrochloride for chemotherapy-induced nausea and vomiting (CINV) prevention, as detailed by Ruhlmann & Herrstedt. The review highlights the unique efficacy of palonosetron, especially in controlling delayed emesis, with discussion of methodological rigor and implications for oncology research.

• Cy3-UTP: Transforming In Vitro Transcription RNA Labeling

  2026-04-29

  Cy3-UTP, a Cy3-modified uridine triphosphate from APExBIO, empowers RNA researchers with robust, photostable fluorescence for in vitro transcription RNA labeling and advanced imaging. Its integration streamlines workflows in RNA-protein interaction studies and enables quantitative, high-resolution tracking of RNA in nanoparticle delivery and cellular dynamics.

• Applied Workflows for the Live-Dead Bacterial Staining Kit

  2026-04-29

  Unlock high-fidelity bacterial viability assessment in complex infection models using APExBIO's Live-Dead Bacterial Staining Kit. This article delivers hands-on protocol enhancements, troubleshooting strategies, and practical insights from cutting-edge nanomaterial research in translational microbiology.

• Live-Dead Bacterial Staining Kit: Advanced Viability Assays

  2026-04-28

  Unlock robust, dual-fluorescent viability assessment for bacterial research with the Live-Dead Bacterial Staining Kit. Discover optimized workflows, troubleshooting strategies, and practical insights drawn from recent jaw osteomyelitis nanomaterial studies.

• Methotrexate as a Folate Antagonist: Workflow, Permeability

  2026-04-28

  Methotrexate’s dual role as a folate antagonist and immunosuppressive agent empowers researchers to dissect apoptosis and inflammation with precision. This guide delivers actionable protocols, troubleshooting insights, and strategic assay enhancements—anchored by high-throughput permeability modeling and APExBIO’s rigorously validated Methotrexate.

• FerroOrange Fe²⁺ Fluorescent Probe: Live-Cell Iron Assay Wor

  2026-04-27

  FerroOrange stands out as a highly specific Fe²⁺ fluorescent probe, enabling precise live-cell detection of ferrous ions for research in iron metabolism and ferroptosis. This guide translates recent neurobiology breakthroughs into optimized workflows, advanced applications, and troubleshooting strategies for reliable intracellular iron detection.

• Jasplakinolide: Beyond Actin Polymerization—Chemical Genetic

  2026-04-27

  Explore Jasplakinolide as a premier actin polymerization inducer and its unique role in chemical genetics, assay optimization, and cytoskeletal research. Gain practical insights and evidence-based protocols not covered in existing resources.

• Dissecting Drug Response in Cancer: Insights from In Vitro M

  2026-04-26

  Schwartz's dissertation advances drug response evaluation in cancer by distinguishing between growth inhibition and cell death metrics in vitro. This nuanced approach clarifies the interpretation of anti-cancer drug efficacy and provides researchers with a more rigorous framework for experimental design and analysis.

• BMX Kinase–Mediated Phosphorylation Regulates Mtb Intracellu

  2026-04-25

  This study uncovers how Mycobacterium tuberculosis (Mtb) promotes its own intracellular survival by exploiting host BMX kinase to phosphorylate ATP6V1E1, impairing lysosomal acidification. The findings illuminate a novel host-pathogen interaction and suggest that BMX kinase inhibitors could inform future host-directed TB therapies.

• AO/PI Double Staining Kit: Practical Guide for Cell Viabilit

  2026-04-24

  The AO/PI Double Staining Kit enables rapid, simultaneous assessment of cell viability, apoptosis, and necrosis using dual fluorescent dyes. This kit is best suited for researchers requiring clear discrimination among live, apoptotic, and necrotic cells in a single workflow. It is not intended for mechanistic pathway analysis beyond viability and death categorization.

• Licoricidin Inhibits HCC Growth and Metastasis via PI3K/AKT

  2026-04-24

  This study demonstrates that licoricidin, a prenylated isoflavone from licorice, suppresses hepatocellular carcinoma (HCC) proliferation and metastasis by targeting PI3K/AKT signaling. The findings highlight licoricidin's potential as a therapeutic agent and provide mechanistic insights for future drug development.

• TAK-715: Precision p38 MAPK Inhibitor for Inflammation Assay

  2026-04-23

  TAK-715 stands out as a highly selective, nanomolar-potency p38 MAPK inhibitor for dissecting cytokine signaling and inflammation pathways. Its dual-action mechanism and robust anti-inflammatory profile make it the premier choice for reliable, reproducible research in chronic inflammatory disease models.

• Canonical Anti-Apoptotic Role of MCL-1 in Breast Cancer Reve

  2026-04-23

  This article discusses a landmark study establishing that breast cancer's dependence on MCL-1 arises from its canonical anti-apoptotic function. The findings clarify the mechanism of MCL-1 in tumor maintenance and reinforce the rationale for using selective MCL-1 inhibitors in apoptosis-focused cancer research.

• Homoharringtonine: Mechanistic Foundations and Translational

  2026-04-22

  Explore the advanced mechanistic profile of Homoharringtonine, a potent cytotoxic alkaloid, and its breakthrough applications in cancer biology and SARS-CoV-2 antiviral research. This article delivers uniquely deep scientific insight and actionable guidance for translational assay development.

16095 records 1/1073 page Next 12345 下5页 Last page